Photobiomodulation With Polarized Light as Adjunctive Treatment in Diabetic Foot Ulcer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04446767

Enrollment

Registered

2020-06-25

Start date

2020-06-30

Completion date

2020-09-05

Last updated

2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing Disorder

Keywords

diabetes, foot ulcer, polarized light, ;wound healing

Brief summary

Effect of Photobiomodulation With Polarized Light on wound healing and aerobic microflora in Diabetic Foot Ulcer

Detailed description

Effect of Photobiomodulation With Polarized Light on wound healing and aerobic microflora in Diabetic Foot Ulcer both sexes were included and intervention will be given for two months, wound healing will be assessed by measuring the surface area and the Aerobic microflora will be isolated and controlled on the basis of bio-gram and antibiogram at the beginning and at the end of treatment.

Interventions

RADIATIONpolarized light

bioptron light therapy sessions, about 12 minutes on the foot ulcer 3 sessions per week for about 8 weeks

OTHERMedical Care

Appropriate day-care and principles of local ulcer therapy, washing and bandaging, use of anti exudative, anti-inflammatory and disinfection solutions will be administered to this group, topical antibiotics will be administered based on bio-gram and antibiogram results

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

50 Years to 70 Years

Healthy volunteers

Inclusion criteria

1. The patients with diagnosed diabetic foot ulcer lasting at least 4 weeks ( sized from 0.5 to 2 cm 2. Cooperative and mentally stable patients .

Exclusion criteria

1. Hepatic patients . 2. Uncontrolled hypertension . 3. Uncontrolled diabetic patients with HbA1c\>8.5% . 4. Neurological disorders . 5. Musculoskeletal disorders that interfere with program . 6. Previous history or any sign of DVT .

Design outcomes

Primary

Measure	Time frame	Description
Wound assessment	two months	The wound surface area (ulcer size), lenghth and width will measured using Ruler technique
Histologic evaluation:	two months	Aerobic microflora will be isolated and controlled on the basis of biogram and antibiogram at the beginning and at the end of treatment

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026